Navigation Links
Verenium to sponsor and present at the 2013 BIO Pacific Rim Summit on Industrial Biotechnology and Bioenergy
Date:12/2/2013

SAN DIEGO, Dec. 2, 2013 /PRNewswire/ -- Verenium Corporation, now part of BASF, today announced that the Company is a sponsor of the upcoming 2013 BIO Pacific Rim Summit on Industrial Biotechnology and Bioenergy.  The conference takes place December 8 – 11, 2013 in San Diego, California.

James Levine, President and Chief Executive Officer, will speak on a panel, Pac Rim CEO Spotlight on Tuesday, December 10th, 8:00 a.m. – 9:30 a.m. PST.

Verenium will also host a workshop entitled, Blue + White= Green? Exploring Marine Biodiversity and Bringing Sustainable Solutions to Industry on Tuesday, December 10th at 9:45 a.m. PST.  Ken Barrett, Vice President of Strategy and Business Development at Verenium will moderate the panel and Verenium's Vice President of R&D Strategy and Partnerships, David Weiner, Ph.D., will present as part of the panel.

For more information on the BIO Pacific Rim Summit on Industrial Biotechnology and Bioenergy visit http://www.bio.org/pacrim.  

About Verenium
Verenium, now part of BASF, is an industrial biotechnology company focused on developing high-performance enzymes for industrial processes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets.  Read more at www.verenium.com.

BASF - The Chemical Company
BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE, Ludwigshafen, Germany. BASF has more than 16,600 employees in North America, and had sales of $18.5 billion in 2012. For more information about BASF's North American operations, visit www.basf.us.

BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. We combine economic success with environmental protection and social responsibility. Through science and innovation, we enable our customers in nearly every industry to meet the current and future needs of society. Our products and solutions contribute to conserving resources, ensuring nutrition and improving quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future. BASF had sales of €72.1 billion in 2012 and more than 110,000 employees as of the end of the year. Further information on BASF is available on the Internet at www.basf.com.

Contacts:

Sarah Carmody
Sr. Manager, Corporate Communications
858-431-8581
sarah.carmody@verenium.com


'/>"/>
SOURCE Verenium Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Harwood Feffer LLP Announces Investigation of Verenium Corporation
2. Verenium Enters Agreement To Be Acquired By BASF
3. Verenium To Present At The Rodman & Renshaw Annual Global Investment Conference
4. Verenium Corporation To Announce Second Quarter 2013 Financial Results
5. Verenium Announces Appointment Of Brian Carter As Vice President Of Grain Processing
6. Verenium To Sponsor And Present At The 2013 Bio World Congress On Industrial Biotechnology
7. Verenium To Introduce New Enzyme Product At 2013 International Fuel Ethanol Workshop & Expo
8. Verenium To Present At Two Upcoming Conferences
9. Verenium Corporation to Announce First Quarter 2013 Financial Results
10. Verenium Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012
11. Verenium Announces Preliminary Financial Results For Fiscal 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... portal. In response to client demand KbioBox developed a sophisticated “3 click” gene ... Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ and powered ...
(Date:12/8/2016)... PRINCETON, N.J. , Dec. 8, 2016 ... late-stage biopharmaceutical company focused on developing and commercializing products ... medical need, announced today that it will be hosting ... 8:30-9:30 am ET on the origins of innate defense ... as a review of oral mucositis and the recently ...
(Date:12/8/2016)... DIEGO , Dec. 8, 2016   ... a leading commercial provider of clinically actionable liquid ... patients, announces that clinical data featuring its Target ... to tissue biopsy for the detection of actionable ... results from research sponsored by Sara Cannon Research ...
(Date:12/7/2016)... /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical company ... products for the treatment of cancer, today announced ... Development Program with Cytovance Biologics ( Oklahoma ... antibody product. Supported by recent positive interim clinical ... ovarian cancer patients, OncoQuest has engaged Cytovance to ...
Breaking Biology Technology:
(Date:11/24/2016)... IRVINE, Calif. , Nov. 23, 2016 ... help endurance athletes and their trainers non-invasively measure ... Variability Index, Pulse Rate, and Respiration Rate in approximately ... Ember enables users easy and immediate access to key ... as part of a training regimen. ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ... Banks and Academics) market is to witness a value of ... the highest Compounded Annual Growth Rate (CAGR) of 10.75% is ... analysis period 2014-2020. North America is ... Europe at 9.56% respectively. Report ...
(Date:11/14/2016)... SARASOTA, Fla., Nov. 14, 2016  xG Technology, Inc. ... in providing critical wireless communications for use in challenging ... ended September 30, 2016. Management will hold a conference ... at 5:00 p.m. Eastern Time (details below). ... announced a $16 million binding agreement to acquire Vislink ...
Breaking Biology News(10 mins):